← All Horizon Space Acquisition Ii CORP filings

Horizon Space Acquisition Ii CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
HSPT
Horizon Space Acquisition Ii CORP
10-Q: Horizon Space Acquisition II Corp. Q1 2026 Update
Horizon Space Acquisition II Corp. reports a net loss for Q1 2026, with significant redemptions and ongoing efforts to complete a business combination.
NASDAQ
HSPT
Horizon Space Acquisition Ii CORP
10-Q: Horizon Space II Reports Q3 2025 Results, SL Bio Merger Progress
Horizon Space Acquisition II Corp. reported a net income of $615,026 for Q3 2025, driven by trust account interest, but faces going concern doubts amid a pending merger with SL Bio Ltd.
NASDAQ
HSPT
Horizon Space Acquisition Ii CORP
10-Q: Horizon Space II to Merge with SL Bio
Horizon Space Acquisition II Corp. announced a definitive business combination agreement with SL Bio Ltd., a cellular and gene therapy developer, while facing significant liquidity challenges.
NASDAQ
HSPT
Horizon Space Acquisition Ii CORP
10-Q: Horizon Space Acquisition II Corp. Reports Net Income for Q1 2025, Announces Business Combination Agreement
Horizon Space Acquisition II Corp. reports a net income of $472,592 for the quarter ended March 31, 2025, and announces a business combination agreement with SL Bio Ltd.
NASDAQ
HSPT
Horizon Space Acquisition Ii CORP
10-Q: Horizon Space Acquisition II Corp. Reports Third Quarter 2024 Results and Provides Update on Business Combination Efforts
Horizon Space Acquisition II Corp. reports a net loss of $33,604 for the three months ended September 30, 2024, and provides an update on its search for a business combination target.